MRI-negative PET-positive temporal lobe epilepsy (TLE) and mesial TLE differ with quantitative MRI and PET: a case control study by Carne, Ross P et al.
  
 
 
 
Carne, Ross P, O’Brien, Terence J, Kilpatrick, Christine J, MacGregor, Lachlan R, Litewka, Lucas, Hicks, Rodney 
J and Cook, Mark J 2007, MRI-negative PET-positive temporal lobe epilepsy (TLE) and mesial TLE differ with 
quantitative MRI and PET: a case control study, BMC neurology, vol. 7, no. 16, pp. 1-13. 
 
 
DOI: 10.1186/1471-2377-7-16 
 
 
 
 
 
 
This is the published version. 
 
©2007, The Authors 
 
Reproduced by Deakin University under the terms of the Creative Commons Attribution Licence 
 
 
 
 
 
 
 
 
 
 
 
Available from Deakin Research Online: 
 
http://hdl.handle.net/10536/DRO/DU:30007557 
 
 
 
 
BioMed CentralBMC Neurology
ssOpen AcceResearch article
'MRI-negative PET-positive' temporal lobe epilepsy (TLE) and 
mesial TLE differ with quantitative MRI and PET: a case control 
study
Ross P Carne*1,3,4,7,9,10, Terence J O'Brien4,6,10, Christine J Kilpatrick4,6,10, 
Lachlan R MacGregor4,8, Lucas Litewka1, Rodney J Hicks2,10 and 
Mark J Cook1,3,5,10
Address: 1Victorian Epilepsy Centre, St Vincent's Hospital, Melbourne, Australia, 2PET Centre, The Peter MacCallum Cancer Institute, Melbourne, 
Australia, 3Department of Neurology, St. Vincent's Hospital, Melbourne, Australia, 4Department of Neurology, The Royal Melbourne Hospital, 
Melbourne, Australia, 5Department of Medicine, St. Vincent's Hospital, Melbourne, Australia, 6Department of Medicine, The Royal Melbourne 
Hospital, Melbourne, Australia, 7Department of Neuroscience, The Geelong Hospital, Barwon Health, Geelong, Australia, 8Department of Clinical 
Epidemiology and Biostatistics, The Royal Melbourne Hospital, Melbourne, Australia, 9School of Medicine, Deakin University, Geelong, Australia 
and 10Faculty of Medicine, The University of Melbourne, Melbourne, Australia
Email: Ross P Carne* - carnero@svhm.org.au; Terence J O'Brien - obrientj@unimelb.edu.au; 
Christine J Kilpatrick - Christine.Kilpatrick@mh.org.au; Lachlan R MacGregor - Lachlan.Macgregor@mh.org.au; 
Lucas Litewka - Lucas.Litewka@svhm.org.au; Rodney J Hicks - Rod.Hicks@petermac.org; Mark J Cook - Mark.COOK@svhm.org.au
* Corresponding author    
Abstract
Background: 'MRI negative PET positive temporal lobe epilepsy' represents a substantial minority of temporal
lobe epilepsy (TLE). Clinicopathological and qualitative imaging differences from mesial temporal lobe epilepsy are
reported. We aimed to compare TLE with hippocampal sclerosis (HS+ve) and non lesional TLE without HS (HS-
ve) on MRI, with respect to quantitative FDG-PET and MRI measures.
Methods: 30 consecutive HS-ve patients with well-lateralised EEG were compared with 30 age- and sex-matched
HS+ve patients with well-lateralised EEG. Cerebral, cortical lobar and hippocampal volumetric and co-registered
FDG-PET metabolic analyses were performed.
Results: There was no difference in whole brain, cerebral or cerebral cortical volumes. Both groups showed
marginally smaller cerebral volumes ipsilateral to epileptogenic side (HS-ve 0.99, p = 0.02, HS+ve 0.98, p < 0.001).
In HS+ve, the ratio of epileptogenic cerebrum to whole brain volume was less (p = 0.02); the ratio of epileptogenic
cerebral cortex to whole brain in the HS+ve group approached significance (p = 0.06). Relative volume deficits
were seen in HS+ve in insular and temporal lobes. Both groups showed marked ipsilateral hypometabolism (p <
0.001), most marked in temporal cortex. Mean hypointensity was more marked in epileptogenic-to-contralateral
hippocampus in HS+ve (ratio: 0.86 vs 0.95, p < 0.001). The mean FDG-PET ratio of ipsilateral to contralateral
cerebral cortex however was low in both groups (ratio: HS-ve 0.97, p < 0.0001; HS+ve 0.98, p = 0.003), and more
marked in HS-ve across all lobes except insula.
Conclusion: Overall, HS+ve patients showed more hippocampal, but also marginally more ipsilateral cerebral
and cerebrocortical atrophy, greater ipsilateral hippocampal hypometabolism but similar ipsilateral cerebral
cortical hypometabolism, confirming structural and functional differences between these groups.
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Temporal lobe epilepsy is the commonest form of refrac-
tory focal epilepsy in adults. About 30% of temporal lobe
epilepsy is due to foreign tissue lesions, whilst 60–70% is
designated "non lesional" (NLTLE). The most common
pathological substrate in this "non-lesional" group is hip-
pocampal sclerosis (HS), present in a majority of medi-
cally refractory cases. Whilst it is difficult to give exact
proportions, given that only patients with intractable sei-
zures undergo full characterisation, around 70% of these
patients with NLTLE are thought to have HS [1]. It is esti-
mated that at least 30% of patients with NLTLE have nei-
ther a foreign tissue temporal lobe lesion nor MRI
evidence of HS (HS-ve).
A previous study by our group demonstrated significant
clinicopathological and qualitative structural and func-
tional imaging differences between TLE associated with
hippocampal sclerosis (HS+ve) and TLE with no evidence
of hippocampal sclerosis on MRI (HS-ve) [2]. Apart from
the lack of evidence of the defining hippocampal sclerosis
(HS) on MRI, HS-ve patients in general showed lateralised
but more widespread temporal hypometabolism on FDG-
PET with blinded visual assessment. This group were
therefore dubbed "MRI negative PET positive TLE". Other
findings in the HS-ve group included a less frequent his-
tory of febrile convulsions; slower rhythms at ictal EEG
onset; less frequent histopathological hippocampal scle-
rosis, and a similarly good post surgical outcome even in
the subgroup of HS-ve patients who had undergone a hip-
pocampal sparing procedure. Further study with Statisti-
cal Parametric Mapping (SPM) has suggested the main
difference between the groups lies in greater hippocampal
hypometabolism in the HS+ve group [3].
Brain volume deficits have been reported in epilepsies
covering a range of syndromes and aetiologies, and to
some extent can be used to differentiate these syndromes
[4-6]. Temporal lobe epilepsy in particular has been asso-
ciated with regional and more widespread areas of
atrophic change, sometimes only evident with detailed
volumetric study [7]. The most obvious structural differ-
ence between HS+ve and HS-ve temporal lobe epilepsy
involves the presence or absence of hippocampal atrophy.
However, an appreciation of more widespread differences
in degree and distribution of volume deficits between
these two groups, if present, may shed light on any possi-
ble pathophysiological differences.
The functional imaging characteristics of these groups are
also of great interest. Many HS-ve patients, as with HS+ve
patients, have prominent focal hypometabolism on FDG-
PET scans [8], with rare false lateralisation. The underlying
pathophysiological basis for the hypometabolism seen in
patients with TLE is still unresolved. While FDG-PET has
shown a high correlation with MRI-identified HS for the
lateralisation of the epileptogenic zone, many studies
have found that the magnitude of the hypometabolism
correlates weakly or not at all with either direct [9] or indi-
rect [10,11](MRI hippocampal volumetry) measures of
hippocampal neuronal loss, even in patients with HS. In
both HS-ve and HS+ve TLE, decreased metabolism may
involve lateral as well as mesial temporal structures. Our
previous study suggested more extensive hypometabolism
in HS-ve patients compared to HS+ve on blinded visual
assessment, extending to more commonly involve tempo-
ral structures beyond anterior or mesial regions [2]. How-
ever, the extent of differential involvement of temporal
sub-regions and remote cortex on FDG-PET is difficult to
quantitate visually.
Given the differences obvious on visual analysis, we were
interested to investigate whether further differing patterns
of structural or functional changes were present between
these TLE subgroups using quantitative and semiquantita-
tive methods. The primary hypothesis was that the epilep-
togenic focus in HS-ve patients involves primarily lateral
rather than mesial temporal structures, and that the quan-
titative structural and functional changes would reflect
this. The current study aimed to investigate this hypothe-
sis by comparing volumetric MRI and coregistered FDG-
PET metabolic measures on scans from HS+ve and HS-ve
TLE patients.
Methods
This study involved the same patient cohort as that from
a previously reported case-control study [2], but on this
occasion consisted of a detailed quantitative assessment
of the patients' MRI and PET scans.
Case Selection
Cases comprised 30 consecutive patients with clinically
and video-EEG defined non-lesional temporal lobe epi-
lepsy (NLTLE) and well-lateralised ictal EEG changes, but
without evidence of HS on MRI, including MR volumetry
(HS-ve). All patients had been admitted for a comprehen-
sive inpatient assessment including video-EEG monitor-
ing between 1996 and 2002 at one of three tertiary referral
hospitals. Controls were 30 age- and sex-matched patients
with well-lateralised unilateral ictal and/or interictal epi-
leptiform EEG discharges and concordant unequivocal
evidence of hippocampal sclerosis on MRI, confirmed by
MR volumetry (HS+ve). The controls were selected by
starting with the most recent HS+ve patient and moving
consecutively retrospectively through the epilepsy moni-
toring database, matching as appropriate for age and sex.
HS-ve patients represented close to 20% of medically
refractory partial epilepsy patients assessed at these insti-
tutions. The study was approved by the institutional ethics
committees of The Royal Melbourne Hospital, St. Vin-Page 2 of 13
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tute. All patients consented to MRI and PET scans as part
of the study.
Historical features in these groups have been previously
described [2]. Significantly there was no difference
between the groups in duration of epilepsy, presence or
type of auras, or pre-operative seizure frequency scores
classified according to a 12-point seizure frequency score
(SFS).
MRI methods
All imaging was performed on a 1.5 Tesla GE Signa (GE
Systems Milwaukee). In addition to standard axial and
sagittal sequences, approximately 124 contiguous T1-
weighted MPRAGE images were acquired, with FOV 24
cm, and a 256*256 matrix, providing in-plane resolution
of 0.98 mm2. Resolution in the Z-plane was 1.5 mm.
Images were obtained using a three-dimensional volume
acquisition sequence in addition to standard sequences.
Data was segmented, using a semi automated, three-
dimensional morphometric protocol to define the struc-
tures of interest. The methods of MRI segmentation and
quantitation have been previously described [12].
Cerebral cortex was extracted by an interactive threshold-
ing method, performed by a single blinded observer, as
described in a previous paper [12]. Hippocampi were
measured according to a well defined protocol [13].
The groups were compared for MRI volumetric measures
of: hippocampus; whole brain; total cerebral cortex; hem-
ispheric volumes ipsilateral and contralateral to seizure
onset; extracted hemispheric cortical volumes ipsi- and
contralateral to seizure onset; and segmented lobar vol-
umes of ipsi- and contralateral frontal, temporal, parietal,
occipital and insular cortices.
FDG-PET Methods
Patients were imaged in the interictal state on a PENN PET
300H Tomograph scanner with sodium iodide crystals,
using a 25.6 cm diameter reconstruction field of view and
3D whole-head acquisition, according to a previously
defined protocol [8]. For the 2 mm slice thickness used for
whole-body imaging, the measured resolution was 4.2
mm at full width at half maximum transaxially and 5.4
mm at full width at half maximum out of plane. The dose
of FDG administered was 37–111 MBq (1–3 mCi). One
bed position was used. All scans were commenced 45
minutes after injection of FDG with the patient lying com-
fortably in a darkened room during the uptake period.
The scan acquisition time was 30–40 minutes to achieve
comparable statistical quality between scans. The dura-
tion of acquisition was based on count rates measured at
the commencement of imaging, achieving total counts of
>40 million. Measured, segmented attenuation correction
was derived from a rotating 'single photon' Cs-137 source.
The data were processed using a Wiener prefilter (scaling
value = 0.5) and ordered-subsets expectation maximiza-
tion (OSEM) iterative reconstruction performed with 4
iterations and 8 subsets. OSEM significantly reduces the
degree of statistical noise in the reconstructed images
compared to previous filtered back projection techniques
on this system. The Wiener pre-filter improved resolution
by enhancing the frequencies that define the resolving
power of the system modulation transfer function (MTF).
The images were reconstructed into a 256 × 250 mm cylin-
dric volume with a 2 mm slice thickness. The reconstruc-
tion process created a standard series of contiguous
images oriented in the transaxial, coronal, sagittal, and
transtemporal planes.
[18F] FDG-PET scans were available for analysis in 30 HS-
ve patients and 27 HS+ve patients. Three of the 27 FDG
PET scans in the HS+ve group were technically subopti-
mal, and did not allow accurate coregistration to be per-
formed. These three HS+ve FDG PET scans all showed
lateralised ipsilateral temporal hypometabolism, and had
been included in the previously published study reporting
visual analyses (Carne et al. 2004). Coregistered FDG-PET
analyses of these HS+ve controls and of the FDG PET
scans of their matched MRI negative PET positive counter-
part cases were not included in this analysis, allowing 27
HS-ve and 24 HS+ve patients to be analysed.
Image Processing for MRI/FDG-PET coregistration
One of the difficulties with quantitation of regional
changes on FDG-PET scans is the relatively lesser anatom-
ical resolution obtained compared to MRI. To overcome
this, the FDG-PET scan was coregistered with the patients
volumetric MRI, and the detailed anatomical structures
defined on the MRI used to accurately quantitate the asso-
ciated metabolic change on the PET (Figure 1).
Coregistration was performed using a surface matching
technique, involving conversion of MRI and FDG-PET to
binary volumes and subsequent matching of surface
points, using the AnalyzeAVW software package (Mayo
Clinic). Binary images representing the cerebral surface
for each scan were obtained by extracting the brain from
extracerebral structures on MRI, as described previously
[12], and thresholding out the extracerebral uptake on
FDG-PET. Interior "holes" were then deleted, to give two
binary single objects representing brain surface as meas-
ured using each modality.
One thousand points on the surface of the first cerebral
binary image (PET) were sampled and the points then
matched to the corresponding surface of the other cere-
bral binary image (MRI) resulting in a 4 × 4 matrix thatPage 3 of 13
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tion of the PET to the MRI image [Jiang H et al., 1992]. The
calculated transformation matrix was then applied to the
original interictal PET image, which resulted in an FDG-
PET scan in the same 3-D space as the MRI. Structures or
regions of interest then defined on MRI were then used to
analyse the same areas on the associated PET, allowing a
detailed structural-functional comparison to be made
(Figure 1). The mean intensity on FDG-PET was then cal-
culated in each of the areas defined at MRI segmentation:
whole cerebrum, lateralised cerebral hemispheres, lateral-
ised hemispheric cerebral cortex, hippocampus (Figure 2),
and frontal, temporal, insular, parietal and occipital lobes
(Figure 1). Further analysis was also performed of the tem-
poral lobes with hippocampus, as defined by ROI on MRI,
removed from the temporal cortex. The ratio of FDG
uptake in ipsilateral (epileptogenic) to the homologous
contralateral region was calculated, with a smaller ratio
indicating a more marked degree of ipsilateral hypome-
tabolism. Ratios of ipsi- and contralateral lobar to whole
brain metabolism, and hippocampus to whole brain were
performed to allow comparison of differential metabolic
effects between lobes.
Statistics
Analysis of ratios of ipsilateral epileptogenic to contralat-
eral volumes was performed. The extent of volume asym-
metry within each group was defined as the mean
ipsilateral (epileptogenic)/contralateral side-to-side ratio.
Brain volumes and PET intensity values were compared
using either the paired t test, or Wilcoxon matched-pairs
signed-ranks test where the distribution was clearly non-
normal. Statistical analysis was performed using Stata Ver-
sion 7.0 [14].
Volumetric MRI and coregistered FDG-PET: (a) MRI Extracted whole brain is segmented into (b) MRI right and left cerebral hemispheres, in turn th shold into (c) MRI right and left cerebra  co t cesFig re 1
Volumetric MRI and coregistered FDG-PET: (a) MRI Extracted whole brain is segmented into (b) MRI right and left cerebral 
hemispheres, in turn thresholded into (c) MRI right and left cerebral cortices. Coregistration of the (d) FDG-PET whole brain 
allows accurate anatomical definition on the metabolic studies of, for example, (e) FDG-PET right and left cerebral hemi-
spheres and (f) FDG-PET right and left cerebral cortices.Page 4 of 13
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MRI Brain Volume
Table 1 compares the results for the MRI derived volumes
for the brain regions between the two groups. There were
no significant differences in mean whole brain volume
between groups (p = 0.56).
The results of analysis of mean hippocampal, cerebral
hemispheric and cerebrocortical hemispheric ratios of
ipsilateral (epileptogenic) side to contralateral volume
ratios are presented in table 2, and graphically in figures
3, 4 and 5. Lower ratios indicate greater ipsilateral atro-
phy. The HS+ve group had marked hippocampal atrophy
(ratio 0.69, p < 0.001), but also were found to have a
small but significant relative ipsilateral cerebral hemi-
spheric atrophy (0.98, p < 0.001). Hippocampal volumes
in the HS-ve group, by definition, were relatively symmet-
rical. Cerebral cortical volumes in the HS-ve group were
also relatively symmetrical, although there was a detecta-
ble minor deficit in ipsilateral cerebral hemispheric vol-
ume (0.99, p = 0.018). When both populations were
compared on a case-control basis, there was not only
greater hippocampal atrophy (p < 0.001) but also a mar-
ginally greater degree of ipsilateral cerebral (p = 0.022)
and possibly cerebrocortical (p = 0.06) atrophy in the
HS+ve group.
Specific measures of hippocampal volume ratios between
the groups were of interest. While the mean volume of the
smaller hippocampus in the HS+ve group (2845 mm3)
differed from the smaller hippocampus in the HS-ve
group (4013 mm3, p < 0.001), there was no detectable
difference in the size of the larger hippocampus between
groups (HS+ve 4091 mm3; HS-ve 4121 mm3, p = 0.83).
Similarly, there was no detectable difference in the mean
volume of the hippocampus contralateral to seizure onset
between groups (HS+ve 4091 mm3; HS-ve 4044 mm3; p
= 0.73).
The absolute cortical lobar volumes and ipsilateral/con-
tralateral ratios are shown in Tables 3 and 4. HS+ve
showed smaller ipsilateral volumes across all lobes except
frontal, however only insular and temporal comparisons
approached statistical significance. HS-ve ipsilateral vol-
umes were in contrast relatively similar to or larger than
contralateral volumes. (Table 4).
Quantitative FDG-PET Analysis
The results of blinded visual analysis in these two groups
of patients were previously described, with clearly lateral-
ised hypometabolism in the majority of both groups: 27/
30 HS-ve patients and 100% of HS+ve patients in whom
PET was performed (27/27) [2]. Where lateralised, the
side of the PET hypometabolism was concordant with
that of the ictal EEG in 26/27 HS-ve and with ictal EEG
and MRI in all HS+ve patients.
Semi-quantitative analysis of hypometabolism using
coregistration confirmed that mesial (hippocampal) ipsi-
lateral hypometabolism, although present in both HS+ve
(ipsi/contralateral ratio 0.86) and HS-ve (ipsi/contralat-
eral ratio 0.95), was more marked in the HS+ve group (p
< 0.001). There was no significant correlation between the
degree of MRI determined volume loss and FDG-PET
determined metabolic asymmetry in either group (corre-
lation coefficients: HS+ve R = 0.26, p > 0.05; HS-ve R =
0.23, p > 0.05): this is particularly obvious in the HS-ve
group where greater ipsilateral/contralateral cortical
(1.01) and hippocampal (1.01) volume ratios contrasted
with markedly lesser ipsilateral/contralateral metabolic
ratios (0.97 and 0.95 respectively). (Table 5).
In contrast to the more marked mesial hypometabolism
in the HS+ve group, lateralised cerebral and cerebrocorti-
cal hypometabolism, although again present in both
HS+ve (ipsi/contralateral ratio 0.98) and HS-ve (ipsi/con-
tralateral ratio 0.97) groups, were similar in the two
groups; if anything, less in the HS-ve group although the
difference was not statistically significant: (cerebral p =
0.107; cerebrocortical p = 0.363).
Comparing these results to the MRI volumetric results
yielded interesting data. The magnitudes of the volume
and metabolic asymmetries showed no significant corre-
lation (R = 0.25, p > 0.05 in both groups). The magnitude
of the side-to-side hippocampal FDG-PET ratio was signif-
icantly less in the HS+ve group (HS+ve:0.86+/-0.08, HS-
ve:0.95+/-0.18, p < 0.001). On blinded visual analysis the
FDG-PET left temporal cortex with coregistered hippocam-pal tracing, coronal sectionigure 2
FDG-PET left temporal cortex with coregistered hippocam-
pal tracing, coronal section.Page 5 of 13
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EEG side in all HS+ve and 25/27 HS-ve patients [2]. The
side of hippocampal hypometabolism by ROI analysis
concurred with EEG side in all HS+ve but only 22/27 HS-
ve patients, suggesting that in some HS-ve cases it is the
changes beyond the hippocampus that allow lateralisa-
tion of the epileptogenic temporal lobe, rather than ipsi-
lateral hippocampal hypometabolism.
Results of cortical ipsilateral/contralateral lobar metabolic
ratios are presented in Tables 6 and 7: lower values again
indicate greater ipsilateral hypometabolism. The striking
finding is that overall in both groups all ipsilateral lobes
were comparatively hypometabolic, except for occipital
lobe bilaterally where the difference was not significant
(HS+ve, p = 0.84; HS-ve p = 0.069), and for HS+ve parietal
lobe (0.98, p = 0.095). The only area where HS+ve
showed greater ipsilateral compared to contralateral
hypometabolism than HS-ve was in hippocampi (0.86
HS+ve vs 0.95 HS-ve, p < 0.001) In all other lobar regions,
HS-ve patients showed similar or greater ipsilateral
hypometabolism, confirming the visual impression of
more widespread and more marked hypometabolism in
the HS-ve group. Interestingly, there was also a suggestion
of more overall temporal cortical hypometabolism ipsilat-
erally in HS-ve, in spite of the more significant mesial
temporal hypometabolism in the HS+ve group (temporal
cortex 0.94 HS+ve vs 0.92 HS-ve, p = 0.111).
Discussion
MRI Volumetric studies
Brain volume abnormalities have been reported in epilep-
sies ranging from primary generalised epilepsies through
to lesional epilepsies [4-6]. There are also reports of pro-
gressive hippocampal volume deficits in patients with
hippocampal sclerosis [15-17], of progressive hippocam-
pal atrophy following status epilepticus [18], of progres-
sive neocortical damage in chronic partial epilepsies [19],
and of progressive temporal lobe atrophy following tem-
poral lobectomy for intractable seizures [20]. Although
these reports associate the atrophic process with epilepsy
pathogenesis, it remains unclear whether these changes
are primary or secondary.
The distribution of atrophy seems relatively specific for
particular epilepsy syndromes [21,22]. In a study of corti-
cal volumes in primary generalised epilepsy patients,
patients had significantly larger cortical grey matter vol-
umes than control subjects [5], most marked in patients
with juvenile myoclonic epilepsy in mesial frontal lobes
[23]. This is in contrast to the atrophy usually detected in
partial epilepsy studies. Hippocampal atrophy is the most
obvious feature on structural MRI in patients with hippoc-
ampal sclerosis [13], however other features of regional
atrophy seem specific to temporal lobe epilepsy associ-
ated with HS. Atrophy of the entorhinal and perirhinal
cortex have been shown to be present in MTLE and not in
Table 1: Hippocampal, cerebral hemispheric and cerebrocortical hemispheric volumes: epileptogenic hemisphere "ipsilateral" and 
hemisphere "contralateral" to seizure onset.
MRI volumetry (cm3) HS+ve n = 30 HS-ve n = 30
Mean Standard deviation Mean Standard Deviation
Total Cerebral 1,230 124.3 1,256 267.2
Ipsilateral Cerebral 527.8 55.63 543.9 117.9
Contralateral Cerebral 536.5 53.52 547.4 118.1
Total Cerebral Cortex 628.3 73.62 613.2 138.2
Ipsilateral Cerebral Cortex 312.3 38.31 307.5 69.80
Contralateral Cerebral Cortex 315.7 35.88 305.4 68.80
Ipsilateral hippocampus 2.845 0.641 4.087 0.889
Contralateral Hippocampus 4.091 0.576 4.044 0.881
Table 2: Ratios of ipsilateral (epileptogenic) to contralateral volumes.
HS+ve mean (SD) p HS-ve mean (SD) p Between Groups:
Hippocampi. 0.69 (0.08) <0.001 1.01 (0.18) 0.08 p < 0.001
Cerebrum. 0.98 (0.02) <0.001 0.99 (0.18) 0.018 p = 0.022
Cerebral Cortex. 0.99 (0.03) 0.08 1.01 (0.19) 0.37 p = 0.06
Key Table 2. The p-value quoted relates to side-to-side comparisons within individuals across the group. The between group comparison relates to 
comparison of the case to the age and sex matched control, performed across the group, rather than being a population comparison of ipsilateral 
to contralateral mean volumes. These data are presented graphically in Figure 3.Page 6 of 13
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alised epilepsies [24]. Even within the atrophic hippoc-
ampus in MTLE there is a predilection for some regions
over others: the hippocampal head is more atrophic than
the hippocampal body and hippocampal tail [25], while
within the parahippocampal region, the entorhinal cortex
is more severely affected than the perirhinal cortex [26-
28]. Sophisticated hippocampal mapping techniques also
show differences between the ipsi- and contralateral hip-
pocampi in the regions most markedly affected, with
marked inward deviation in the Sommer sector of the
MTS hippocampi, and subicular but minimal Sommer
sector involvement in the contralateral hippocampus
[29].
Past studies of MRI negative TLE have not shown the con-
sistent widespread volume deficits associated with hip-
pocampal atrophy [30]. Extratemporal focal epilepsies
more often have been shown to have demonstrable vol-
ume loss involving the predominant region or lobe
affected [31,32]. In the study by Briellmann et al, hemicra-
nial volume ipsilateral to the epileptogenic side was
smaller in temporal lobe epilepsy patients, both with and
without histopathologically proven HS, however ipsilat-
Table 3: Cortical lobar volumes ipsilateral and contralateral to seizure onset.
MRI Volumetry (cm3) HS+ve HS-ve
Ipsilat Contralat Ipsilat Contralat
Mean SD Mean SD Mean SD Mean SD
Frontal Cortex 114.7 15.91 113.6 15.77 110.5 25.07 110.7 25.30
Temporal Cortex 79.28 11.70 81.441 10.64 79.11 20.28 78.49 19.78
Parietal Cortex 85.78 13.99 86.44 12.76 85.83 22.09 82.34 20.34
Occipital Cortex 26.34 6.738 25.77 6.386 25.48 7.290 25.72 6.690
Insular Cortex 7.160 1.242 7.500 1.029 7.168 1.670 7.080 1.794
MRI volumetric comparisons: HS-ve versus HS+veFigure 3
MRI volumetric comparisons: HS-ve versus HS+ve. Case-control pairs are presented in order of ascending age. Ratios pre-
sented relate to epileptogenic/contralateral MRI volumes: hippocampus. Mean and standard deviation figures are given in Table 
2.
MRI Volume Ratios: Epileptogenic/contralateral hippocampus
0.4 0.6 0.8 1 1.2 1.4 1.6
Patient Pair (case-
control)
Ra
tio
HS-ve cases
HS+ve controlsPage 7 of 13
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finding which our study has confirmed [32].
This study is the first to our knowledge examining volume
deficits across segmented cortical lobes in a large group of
TLE patients with MRI normal to visual inspection. Ques-
tions have remained as to whether this group has his-
topathological HS without detectable hippocampal
atrophy or T2 signal changes on MRI, or may have bilat-
eral HS making detection difficult on volumetric imaging.
It can be assumed from past studies that there are vary-
ingly subtle regional volume deficits in the HS+ve group,
ranging from obvious hippocampal deficits through to
subtle hemicerebral or whole brain abnormalities. The
finding of small but significant differences in ipsilateral
cerebral and cerebrocortical hemispheric volumes
between the HS+ve and HS-ve groups is further evidence
of a difference between these two groups, with a locore-
gional difference in emphasis in structures most involved.
Analysis by lobar subdivisions underlined these regional
differences. Comparison of ipsilateral to contralateral
lobar cerebral cortical volumes suggested that all lobes in
HS+ve patients were smaller ipsilaterally except for frontal
MRI volumetric comparisons: HS-ve versus HS+veFigure 4
MRI volumetric comparisons: HS-ve versus HS+ve. Case-control pairs are presented in order of ascending age. Ratios pre-
sented relate to epileptogenic/contralateral MRI volumes: cerebrum. Mean and standard deviation figures are given in Table 2.
Epileptogenic/contralateral cerebrum
0.85 0.9 0.95 1 1.05 1.1 1.15
Patient Pair (case-
control)
R
at
io
HS-ve cases
HS+ve controls
Table 4: Ratios of ipsilateral (epileptogenic) to contralateral volumes.
HS+ve mean (SD) p HS-ve mean (SD) p Between groups
Frontal 1.01 (0.26) 0.19 1.00 (0.25) 0.82 p = 0.24
Temporal 0.98 (0.26) 0.09 1.01 (0.20) 0.60 p = 0.18
Parietal 0.99 (0.26) 0.63 1.04 (0.21) 0.016 p = 0.08
Occipital 0.97 (0.27) 0.32 0.99 (0.27) 0.67 p = 0.84
Insular 0.95 (0.11) 0.035 1.03 (0.22) 0.60 p = 0.039
Key Tables 4-7. The p-value quoted relates to side-to-side comparisons within individuals across the group. The between group comparison relates 
to comparison of the case to the age and sex matched control, performed across the group, rather than being a population comparison of ipsilateral 
to contralateral mean volumes.Page 8 of 13
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side was small overall (at 0.99 ipsilateral/contralateral
ratio), and this difference was accounted for by differences
across most lobes. Greatest differences were seen in insu-
lar (0.95) and occipital (0.97) lobes, followed by tempo-
ral (0.98) and parietal lobes (0.99). The reported ratio
represents the mean ratio across the group; the p value
relates to a paired samples comparison of ipsilateral ver-
sus contralateral volume differences within the same
patient across the group, hence the most significant differ-
ences do not necessarily correspond with the lowest mean
ratios: insular (p = 0.035) cortical atrophy was most
marked here, with temporal cortical atrophy (p = 0.09)
approaching significance.
HS-ve patients interestingly and contrastingly showed
larger ipsilateral/contralateral ratios in all lobes except
occipital (0.99, p = 0.67), with parietal cortex most mark-
edly larger ipsilaterally (1.04, p = 0.016). This contrasts
also with the finding of whole ipsilateral cerebral hemi-
spheric atrophy (0.99), suggesting that the mild ipsilateral
cerebral volume loss in the HS-ve group relates to white
matter rather than cortical volume deficit.
The unexpected finding of larger ipsilateral parietal cortex
in the HS-ve group is perhaps a chance finding relating to
use of multiple comparisons, although the finding of
larger cortical volumes in patients with epilepsy does have
precedent in the primary generalized epilepsy literature
Table 5: FDG-PET mean intensity: Cerebrum, Cerebral cortex and Hippocampi. Ipsilateral/Contralateral Ratios: lower ratios indicate 
greater ipsilateral hypometabolism.
HS+ve mean (SD) n = 24 p HS-ve mean (SD) n = 27 p Between Groups:
Hippocampi 0.86 (0.09) <0.001 0.95 (0.06) <0.001 p < 0.001
Cerebrum. 0.98 (0.02) <0.001 0.97 (0.18) <0.001 p = 0.107
Cerebral Cortex. 0.98 (0.03) 0.002 0.97 (0.18) <0.001 p = 0.363
MRI volumetric comparisons: HS-ve versus HS+veFigure 5
MRI volumetric comparisons: HS-ve versus HS+ve. Case-control pairs are presented in order of ascending age. Ratios pre-
sented relate to epileptogenic/contralateral MRI volumes: cerebral cortex. Mean and standard deviation figures are given in 
Table 2.
Epileptogenic/contralateral cerebral cortex
0.85 0.9 0.95 1 1.05 1.1 1.15
Patient Pair (case-
control)
Ra
tio
HS-ve cases
HS+ve controlsPage 9 of 13
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was the insular comparison, with the ipsilateral atrophy in
the HS+ve group (0.95) markedly greater than in the HS-
ve group (1.03) (p = 0.039): this is supported by the
known involvement of insular cortex in mesial temporal
lobe epilepsy [33]. Temporal cortical lobar atrophy was
also possibly more marked in the HS+ve group (0.98 vs
1.01 HS-ve, p = 0.11). These findings support the conten-
tion that HS+ve extends to involve structures distant from
the mesial temporal lobe, with more widespread evidence
of cortical atrophy, and also that HS+ve differs from HS-
ve in the site of predominant involvement, with relatively
preserved cortical volumes but hemicranial volume defi-
cits in the HS-ve group.
Coregistration FDG-PET Regional Quantitations
The striking finding of ipsilateral hypometabolism in
both groups in virtually all brain regions confirms the
impression of a widespread functional deficit in patients
in both groups of non lesional TLE. Although differences
are present, the similarities between these groups are also
interesting. Both groups have most marked hypometabo-
lism in the temporal lobes, maximal mesially in the
HS+ve group. Beyond the temporal lobes, hypometabo-
lism was similar, although in the HS-ve group this trended
towards being more marked (e.g. parietal 0.97 HS-ve vs
0.98 HS+ve, p = 0.084): a small difference if present, but
a marked contrast to the mesially focussed hypometabo-
lism in the HS+ve group (0.95 HS-ve vs 0.86 HS+ve, p <
0.001). Exclusion of hippocampi confirmed the impres-
sion that hippocampi bear the brunt of the functional def-
icit in HS+ve [3], but are also involved in HS-ve.
A potential limitation of this study involves the use of
multiple comparisons, and it is possible that with multi-
ple statistical tests that some of the results will arise by
chance. In this situation it is appropriate, however, to
interpret data based on the primary hypothesis, in this
case that the epileptogenic focus in HS-ve patients
involves primarily lateral rather than mesial temporal
structures, and that the quantitative structural and func-
tional changes would reflect this: that ipsilateral atrophy
and hypometabolism would be present, and that the
extent of hypometabolism would be greater in HS-ve,
where the focus was posited to be lateral rather than
mesial. The data presented relate either to structural or
metabolic asymmetry and deal directly with this primary
hypothesis. The reporting of supportive results in combi-
nation with a constellation of low or trending-low p val-
ues in support of this theory is compelling.
Table 7: FDG-PET mean intensity: Cerebral cortical lobar ratios to whole brain mean: lower ratios indicate greater hypometabolism. 
WBM: whole brain mean; ipsi = ipsilateral; contra = contralateral.
Ratios to Whole Brain Mean 
FDG-PET intensity.
HS+ve HS-ve
Ipsi/WBM mean (SD) Contra/WBM mean (SD) Ipsi/WBM mean (SD) Contra/WBM mean (SD)
Frontal Cortex 1.123 (0.40) 1.145 (0.41) 1.11 (0.28) 1.13 (0.29)
Temporal Cortex 0.934 (0.30) 0.987 (0.32) 0.91 (0.24) 0.99 (0.25)
Parietal Cortex 1.135 (0.35) 1.150 (0.40) 1.11 (0.28) 1.14 (0.29)
Occipital Cortex 1.136 (0.41) 1.133 (0.41) 1.14 (0.29) 1.16 (0.30)
Insular Cortex 1.044 (0.07) 1.099 (0.07) 1.03 (0.20) 1.09 (0.21)
Temporal Cortex, hippocampi 
excluded
0.941 (0.39) 0.995 (0.41) 0.97 (0.25) 0.95 (0.19)
Hippocampus 0.692 (0.07) 0.791 (0.07) 0.760 (0.15) 0.801 (0.17)
Table 6: FDG-PET mean intensity: Cerebral cortical lobes. Ipsilateral/Contralateral Ratios: lower ratios indicate greater ipsilateral 
hypometabolism.
HS+ve mean (SD) p HS-ve mean (SD) p Between Groups: p
Frontal Cortex 0.98 (0.35) 0.032 0.98 (0.25) 0.009 0.818
Temporal Cortex 0.94 (0.31) <0.001 0.92 (0.24) <0.001 0.111
Parietal Cortex 0.98 (0.35) 0.095 0.97 (0.25) <0.001 0.113
Occipital Cortex 1.00 (0.36) 0.844 0.98 (0.25) 0.069 0.202
Insular Cortex 0.94 (0.06) <0.001 0.95 (0.19) 0.001 0.456
Hippocampi 0.86 (0.09) <0.001 0.95 (0.06) <0.001 <0.001
Temporal Cortex, 
hippocampi 
excluded.
0.94 (0.30) <0.001 0.92 (0.18) 0.196 0.135Page 10 of 13
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patients with lateralised concordant hypometabolism on
FDG PET scanning was high, both by visual and semi
quantitative analyses. In a previous study, the extent of
hypometabolism on PET was found to extend more fre-
quently beyond anterior and or mesial temporal regions
alone to involve other temporal or extratemporal regions
in the HS-ve group [2]. Other features of the HS-ve group
suggested that the focus in the group of patients does not
lie mesially, but is more likely to involve the lateral tem-
poral neocortex.
Other groups have noted the difference in the FDG PET
findings between temporal lobe epilepsy patients with
primarily mesial and lateral foci. One study [34] found
significant differences between mesial and lateral TLE in
similar pattern: that study included 35 patients with lat-
eral TLE, only 11 of whom were non lesional, the remain-
der of whom had CD, vascular malformations or
tumours. They found that hypometabolism was more
prominent in the lateral structures than mesial in both
groups, which differs from our finding in the mesial group
with proven hippocampal sclerosis who had more
marked mesial hypometabolism, a finding also reported
by other groups [35]. It is interesting though to compare
the findings in the lateral group in that study, where the
majority had observed structural lesions – the best 'gold
standard' for seizure onset localization – with our study
where structural lesions were not evident. This similar pat-
tern of hypometabolic involvement in our non lesional
group suggests a lateral temporal onset in the HS-ve
patients.
This striking mesial/hippocampal emphasis in the HS+ve
group suggests that this group may be relatively homoge-
nous in its involvement of mesial structures/hippocam-
pus, whereas there is no corresponding single structure or
area that is consistently involved in the HS-ve group. This
raises the question as to whether the non lesional group is
a disease, a syndrome, or a collection of unrelated entities
that have in common no clear epileptogenic lesion on the
MRI. The temptation to define this group as temporal lobe
epilepsy that is not "HS" can to some extent be countered
by the findings on FDG-PET, a positive feature for defini-
tion that clearly differentiates the group from extratempo-
ral epilepsies, and the MRI, which differentiates the group
from MTLE. Beyond this it is possible that HS-ve temporal
lobe epilepsy represents a group with diverse aetiologies,
but on balance highly unlikely given the overall similari-
ties otherwise on structural, functional and histopatho-
logical comparisons.
The pathophysiology underlying the hypometabolism
seen on FDG PET in temporal lobe epilepsy remains
uncertain, and although predictably observed and well
described is not well explained by observed macro or
microstructural alterations. The area of hypometabolism
on FDG PET is generally thought much larger than the
area of presumed pathological involvement [36], though
the widespread extent of both hypometabolism and corti-
cal atrophy in both groups is confirmed by our study.
Electroclinical studies suggest that the pattern of hypome-
tabolism may relate to both the onset of the ictal dis-
charge and to the patterns of preferential spread [37]. A
relationship between interictal slow wave activity and
FDG PET hypometabolism may indicate that the
hypometabolic area represents a region of increased neu-
ronal inhibition which can receive interictal and ictal
propagation [38]. Quantitative FDG-PET uptake studies
have shown the most marked deficits when comparing
HS+ve TLE patients to controls bilaterally in frontal and
parietal lobes, in comparison to the more marked abnor-
malities detected in temporal lobes with asymmetry indi-
ces [39]. There is conflicting evidence as to whether the
extent or severity of hypometabolism relates to neuronal
loss [40,9,11], duration of prior habitual seizures [41,42]
or severity of seizures [43]. In our study, the finding of sig-
nificant mesial hypometabolism in the MRI negative (HS-
ve) group, despite volumetrically normal hippocampi, is
evidence against the contention that volume loss and
hypometabolism are significantly correlated. This also
argues against partial volume effect being a major contri-
bution to the results at the hippocampal level. Neverthe-
less, this contribution cannot be excluded, and is a
potential limitation of the study. Further analysis with
partial volume correction, or alternatively with voxel
based morphometric methods to more closely delineate
sites of structural or metabolic heterogeneity may help to
clarify this further. Even in our HS+ve group, there was
not a significant correlation between degrees of MRI volu-
metric and FDG-PET metabolic asymmetry (correlation
coefficient 0.26). The fact that hypometabolism is inde-
pendent of neuronal loss perhaps accounts for it being an
independent predictor of surgical outcome [44-46].
Another potential limitation of the study is that we did
not assess for changes in smaller subregions of the brain.
The large structures assessed (i.e. hemispheres) are heter-
ogeneous and therefore focal changes at lobar and sublo-
bar levels could easily have been missed. However, the
limited number of subjects that were available for inclu-
sion in this study did not allow the statistical power to
assess multiple regions of interest. Future studies, involv-
ing larger numbers of patients, should extend from our
results by investigating for regional changes particularly in
the cortex.
The smaller hemicranial volumes and varying but almost
ubiquitous hypometabolism on the side of the epilep-
togenic focus occurring irrespective of the presence orPage 11 of 13
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differing pathological process in the hemisphere to that in
the hippocampus, or is this the same process with a differ-
ence in regional emphasis? There is little or no structural
histopathological evidence to suggest that the associated
findings in the lateral neocortex and hemispheric struc-
tures differ significantly between the groups; given this,
perhaps the latter hypothesis seems the most valid. Such
differences in location of primary involvement may derive
from differential timing of an initial insult: for instance
given differential embryological timing of hippocampal
and adjacent neocortical development, it is conceivable
that a precisely timed embryological insult could affect
one region with relative sparing of the other; with the sub-
sequent response of surviving cortex determining the
degree of the eventual predilection towards epileptogene-
sis, an interesting hypothesis that will require further
study.
Conclusion
Overall, HS+ve patients showed more hippocampal, but
also marginally more ipsilateral cerebral and cerebrocorti-
cal atrophy, greater ipsilateral hippocampal hypometabo-
lism but similar ipsilateral cerebral cortical
hypometabolism, confirming structural and functional
differences between these groups, in support of the clini-
cal findings which suggest that these two groups represent
differing syndromes.
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